Upgrade to SI Premium - Free Trial

Johnson & Johnson (JNJ) PT Raised to $185 at Goldman Sachs

July 17, 2025 6:07 AM
Goldman Sachs analyst Asad Haider raised the price target on Johnson & Johnson (NYSE: JNJ) to $185.00 (from $177.00) while ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles